Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Making Strides in Rheumatoid Arthritis
-
- Stay Current With Our Peer-Tested Content
- 6 Highly Read Articles from ACR 2015 Highlight Rheumatoid Arthritis
- FDA Accepts Amgen’s Biologics License Application for Biosimilar to Adalimumab
- ACR Encourages Safe Adoption of Biosimilars During FDA Public Hearing on Biosimilar to Infliximab
- FDA Approves Secukinumab for Treatment of Ankylosing Spondylitis and Psoriatic Arthritis
- FDA Arthritis Advisory Committee Votes in Favor of Biosimilar to Infliximab
- Rheumatoid Arthritis is a Brave New World Leonard H. Calabrese, DO
- Monitoring the Patient With Rheumatoid Arthritis for Disease Progression
-
- EULAR Releases Recommendations for the Care of Patients With Familial Mediterranean Fever
- NICE Releases Guidance for Use of Biologics in Treatment of Rheumatoid Arthritis
- Comorbidity at Disease Onset Seen in Half of Patients With Early RA
- Nearly 40% of Patients May Have Persistent Pain Following Chikungunya Infection
- Patients With Fibromyalgia May Fit One of Two Distinct Subclusters
- Famciclovir, Celecoxib Combo Found Effective to Treat Fibromyalgia
- Phosphodiesterase-5 Inhibitors May Ease Symptoms of Raynaud’s Syndrome
- Update on Herpes Zoster Studies Presented at ACR 2015
-
- Audit on Early RA: Most Patients Wait Too Long for Specialist Care
- Galapagos and Gilead Complete Filgotinib Collaboration
- Protagen AG Joins RA-Map Consortium Seeking Predictors of RA Remission